Tehmasp Rehman Mirza

7PUBLICATIONS
28CO-AUTHORS
Pharmaceutical delivery technologiesGene and molecular therapyCardiology (incl. cardiovascular diseases)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 28, 2026
Comparison of the Safety and Effectiveness of Apixaban Versus Rivaroxaban in Acute Venous Thromboembolism: A Propensity-Matched Real-World TriNetX Study with Obesity and Cancer Subgroup Analyses.

|Jun 26, 2026
Clinical Outcomes of GLP-1 Receptor Agonist and SGLT2 Inhibitor Combination Therapy in Heart Failure: A Real-World Propensity-Matched TriNetX Analysis.

|Jun 25, 2026
Cardiovascular Outcomes with Colchicine in Coronary Artery Disease and HFpEF: A Propensity-Matched TriNetX Analysis.

|May 27, 2026
Comparative Effectiveness of Finerenone Versus SGLT2 Inhibitors in Patients with HFpEF and CKD: A Real-World Propensity-Matched TriNetX Analysis.

|Feb 18, 2026
Rising trends in obesity and cancer-related mortality in the United States: a population-based analysis, 1999-2020.

Faizan Ahmed, Tehmasp Rehman Mirza, Mohamed Bakr

|Nov 26, 2025
Extended Dual Versus Single Anti-Platelet Therapy Following Percutaneous Coronary Intervention: A Bayesian Meta-Analysis and Regression on All-Cause Mortality.

Faizan Ahmed, Faseeh Haider, Ramsha Ali

Pageof 2

Frequent Collaborators

4 joint publications

Najam Gohar

4 joint publications

Muhammad Hussain

4 joint publications

Muhammad Hassan

4 joint publications

Mohammad Omar Butt